Nvidia, AMD to pay 15% of China chip sales revenue to US govt- FT
Saba Capital Management, L.P., a significant stakeholder in Gabelli Healthcare & WellnessRx Trust (NYSE:GRX), recently acquired an additional 14,833 shares of common stock. The transaction, dated January 10, 2025, was executed at a price of $9.57 per share, amounting to a total purchase value of $141,951. Following this acquisition, Saba Capital's total holdings in the trust stand at 1,925,867 shares. This transaction reflects the ongoing investment activities of Saba Capital, led by Boaz Weinstein, who holds a ten percent ownership stake in the trust valued at approximately $152.16 million by market capitalization. InvestingPro analysis reveals the trust generally trades with low price volatility, with several additional insights available to subscribers.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.